Loading...

CV CAPSOVISION INC US FDA Inspections 8-K Filing

CPSV

CV

CAPSOVISION INC

(CV)

2025 8-K

Annual Financial Results

Funding Agreement Signed

Development Agreement Update

FDA Submission Update

Financial Results Released

FDA Application Update

Management Change

Management Changes

Management Change

Financial Results Update

Initial Public Offerings

External Links:

On December 29, 2025, CapsoVision, Inc. announced the submission of its 510(k) application to the FDA for its AI-assisted module related to CapsoCam Plus®. This filing is considered significant and holds a positive sentiment for equity investors.

AI Assistant

CAPSOVISION INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.